Inhibition of allergic reactions by chromoglycate and by a new anti-allergic drug (10-chloro-1,4,6,9-tetrahydro-4,6-dioxopyrido (3,2-g) quinoline-2,8-dicardoxylic acid). I. Activity in rats.
作者信息
Johnson H G, van Hout C A
出版信息
Int Arch Allergy Appl Immunol. 1976;50(4):446-53. doi: 10.1159/000231534.
PMID:55394
Abstract
A new inhibitor of IgE-mediated allergic reactions has been studied in rats. This new inhibitor is chemically quite different from cromoglycate and shows qualitative and quantitative advantages over it. This new inhibitor possesses no bronchodilator or end-organ antagonism activity, but as cromoglycate acts by inhibition of mediator release. Multiple doses in rats lead to tachyphylaxis. This effect is reversed both by decreasing the first dose and increasing the time between doses.
摘要
相似文献
1
Inhibition of allergic reactions by chromoglycate and by a new anti-allergic drug (10-chloro-1,4,6,9-tetrahydro-4,6-dioxopyrido (3,2-g) quinoline-2,8-dicardoxylic acid). I. Activity in rats.
Int Arch Allergy Appl Immunol. 1976;50(4):446-53. doi: 10.1159/000231534.
2
Inhibition of allergic reactions by cromoglycate and by a new anti-allergy drug U-42,585E. I. Activity in rats.色甘酸酯和新型抗过敏药物U - 42,585E对过敏反应的抑制作用。I. 在大鼠中的活性
Int Arch Allergy Appl Immunol. 1978;56(5):416-23. doi: 10.1159/000232051.
3
Inhibition of allergic reactions by cromoglycate and by a new anti-allergic drug(10-chloro-1,4,6,9-tetrahydro-4,6-dioxopyrido(3,2-g)quinoline-2,8-dicarboxylic acid). II. Activity in primates against aerosolized Ascaris suum antigen.色甘酸及一种新型抗过敏药物（10-氯-1,4,6,9-四氢-4,6-二氧代吡啶并[3,2-g]喹啉-2,8-二羧酸）对过敏反应的抑制作用。II. 在灵长类动物中对雾化猪蛔虫抗原的活性。
Int Arch Allergy Appl Immunol. 1976;50(4):454-62. doi: 10.1159/000231535.
4
Inhibition of immediate hypersensitivity reactions in the rat by ICI 74,917 and disodium cromoglycate.ICI 74,917和色甘酸二钠对大鼠速发型超敏反应的抑制作用。
Int Arch Allergy Appl Immunol. 1975;49(4):417-27. doi: 10.1159/000231425.
5
Synthesis and antiallergic activities of 1,3-oxazolo[4,5-h]quinolines.1,3-恶唑并[4,5-h]喹啉的合成及其抗过敏活性
J Med Chem. 1985 Sep;28(9):1255-9. doi: 10.1021/jm00147a023.
6
7
Anti-allergic effects of ketanserin on animal models of allergic reactions.酮色林对过敏反应动物模型的抗过敏作用。
Arch Int Pharmacodyn Ther. 1990 Sep-Oct;307:172-82.
8
Effects of quinotolast, a new orally active antiallergic drug, on experimental allergic models.新型口服活性抗过敏药物喹诺司特对实验性过敏模型的影响。
Jpn J Pharmacol. 1993 Sep;63(1):73-81. doi: 10.1254/jjp.63.73.
9
Pharmacology of a new orally active antiallergic: pyrido[1,2-a]pyrimidine, ucb L140 (CHINOIN 1045) in rats.一种新型口服活性抗过敏药物：吡啶并[1,2-a]嘧啶，UCB L140（奇诺因1045）在大鼠体内的药理学
Int Arch Allergy Appl Immunol. 1982;67(4):362-8. doi: 10.1159/000233048.
10
Inhibition of immediate hypersensitivity reactions by disodium cromoglycate.色甘酸二钠对速发型超敏反应的抑制作用。
Clin Exp Immunol. 1973 Apr;13(4):537-44.
引用本文的文献
1
The characterization of lodoxamide, a very active inhibitor of mediator release, in animal and human models of asthma.洛度沙胺（一种非常有效的介质释放抑制剂）在哮喘动物和人体模型中的特性研究。
Agents Actions. 1986 Jun;18(3-4):301-5. doi: 10.1007/BF01964988.
Zotero 插件